TWST
Twist Bioscience Corp
NASDAQ: TWST · HEALTHCARE · DIAGNOSTICS & RESEARCH
$56.85
-2.89% today
Updated 2026-05-08
Market cap
$3.71B
P/E ratio
—
P/S ratio
9.05x
EPS (TTM)
$-1.32
Dividend yield
—
52W range
$23 – $66
Volume
1.2M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+5.8
Quality
C+2.0
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
-0.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$61.88
+8.85%
12-Month target
—
—
Intrinsic (DCF)
$129.30
Margin of safety
+61.61%
1 Strong Buy7 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 19.30% QoQ
+ 61.61% below intrinsic value
Risks
- Altman Z -0.56 — distress zone
- Thin margins at -19.90%
- Negative free cash flow $-25.55M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $203.56M | $245.11M | $312.97M | $376.57M | $409.48M |
| Net income | $-217.86M | $-204.62M | $-208.73M | $-77.67M | $-44.02M |
| EPS | — | — | — | — | $-1.32 |
| Free cash flow | $-226.24M | $-170.25M | $-69.17M | $-75.63M | $-25.55M |
| Profit margin | -107.02% | -83.48% | -66.69% | -20.63% | -19.90% |
Peer comparison
Smart narrative
Twist Bioscience Corp trades at $56.85. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -0.56, it sits in the distress. TTM revenue stands at $409.48M. with profit margins at -19.90%. Our DCF model estimates intrinsic value at $129.30.
Frequently asked questions
What is Twist Bioscience Corp's stock price?
Twist Bioscience Corp (TWST) trades at $56.85.
Is Twist Bioscience Corp overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell). DCF value $129.30.
What is the price target of Twist Bioscience Corp (TWST)?
The analyst target price is $61.88, representing +8.8% upside from the current price of $56.85.
What is the intrinsic value of Twist Bioscience Corp (TWST)?
Based on our DCF model, intrinsic value is $129.30, a +61.6% margin of safety versus $56.85.
What is Twist Bioscience Corp's revenue?
TTM revenue is $409.48M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-0.56 — distress.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio9.05x
ROE-18.20%
Beta2.23
50D MA$51.21
200D MA$37.79
Shares out0.06B
Float0.06B
Short ratio—
Avg volume1.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—